Article
Rapid and slow benzbromarone elimination phenotypes in man: benzbromarone and metabolite profiles.
European journal of clinical pharmacology - 1 Jan 1990
Walter-Sack I, de Vries J X, Ittensohn A, Weber E
Abstract excerpt
Following oral administration of the uricosuric drug benzbromarone two major metabolites appear in the circulation. 1'-hydroxy-benzbromarone (M1), and a second product (M2) of unknown structure. The plasma concentrations of the parent drug and of M1 and M2 have now been compared in two different elimination phenotypes. 10 subjects who eliminated the drug rapidly (S1-10) and one individual (S11) whose elimination...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
